285 related articles for article (PubMed ID: 28327602)
1. Glucocorticoid suppression of osteocyte perilacunar remodeling is associated with subchondral bone degeneration in osteonecrosis.
Fowler TW; Acevedo C; Mazur CM; Hall-Glenn F; Fields AJ; Bale HA; Ritchie RO; Lotz JC; Vail TP; Alliston T
Sci Rep; 2017 Mar; 7():44618. PubMed ID: 28327602
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistance.
Tang SY; Herber RP; Ho SP; Alliston T
J Bone Miner Res; 2012 Sep; 27(9):1936-50. PubMed ID: 22549931
[TBL] [Abstract][Full Text] [Related]
3. Hormonal Regulation of Osteocyte Perilacunar and Canalicular Remodeling in the Hyp Mouse Model of X-Linked Hypophosphatemia.
Tokarz D; Martins JS; Petit ET; Lin CP; Demay MB; Liu ES
J Bone Miner Res; 2018 Mar; 33(3):499-509. PubMed ID: 29083055
[TBL] [Abstract][Full Text] [Related]
4. YAP and TAZ Mediate Osteocyte Perilacunar/Canalicular Remodeling.
Kegelman CD; Coulombe JC; Jordan KM; Horan DJ; Qin L; Robling AG; Ferguson VL; Bellido TM; Boerckel JD
J Bone Miner Res; 2020 Jan; 35(1):196-210. PubMed ID: 31610061
[TBL] [Abstract][Full Text] [Related]
5. Investigating Osteocytic Perilacunar/Canalicular Remodeling.
Yee CS; Schurman CA; White CR; Alliston T
Curr Osteoporos Rep; 2019 Aug; 17(4):157-168. PubMed ID: 31227998
[TBL] [Abstract][Full Text] [Related]
6. Parallel mechanisms suppress cochlear bone remodeling to protect hearing.
Jáuregui EJ; Akil O; Acevedo C; Hall-Glenn F; Tsai BS; Bale HA; Liebenberg E; Humphrey MB; Ritchie RO; Lustig LR; Alliston T
Bone; 2016 Aug; 89():7-15. PubMed ID: 27085457
[TBL] [Abstract][Full Text] [Related]
7. Evidence that osteocyte perilacunar remodelling contributes to polyethylene wear particle induced osteolysis.
Ormsby RT; Cantley M; Kogawa M; Solomon LB; Haynes DR; Findlay DM; Atkins GJ
Acta Biomater; 2016 Mar; 33():242-51. PubMed ID: 26796208
[TBL] [Abstract][Full Text] [Related]
8. Effect of glucocorticoids on osteoclast function in a mouse model of bone necrosis.
He M; Wang J; Wang G; Tian Y; Jiang L; Ren Z; Qiu C; Fu Q
Mol Med Rep; 2016 Aug; 14(2):1054-60. PubMed ID: 27277157
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids cause mandibular bone fragility and suppress osteocyte perilacunar-canalicular remodeling.
Alemi AS; Mazur CM; Fowler TW; Woo JJ; Knott PD; Alliston T
Bone Rep; 2018 Dec; 9():145-153. PubMed ID: 30306100
[TBL] [Abstract][Full Text] [Related]
10. Osteocyte-Intrinsic TGF-β Signaling Regulates Bone Quality through Perilacunar/Canalicular Remodeling.
Dole NS; Mazur CM; Acevedo C; Lopez JP; Monteiro DA; Fowler TW; Gludovatz B; Walsh F; Regan JN; Messina S; Evans DS; Lang TF; Zhang B; Ritchie RO; Mohammad KS; Alliston T
Cell Rep; 2017 Nov; 21(9):2585-2596. PubMed ID: 29186693
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Osteocytes: Techniques for Studying Morphological and Molecular Changes Associated with Perilacunar/Canalicular Remodeling of the Bone Matrix.
Dole NS; Yee CS; Schurman CA; Dallas SL; Alliston T
Methods Mol Biol; 2021; 2230():303-323. PubMed ID: 33197021
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D regulates osteocyte survival and perilacunar remodeling in human and murine bone.
Rolvien T; Krause M; Jeschke A; Yorgan T; Püschel K; Schinke T; Busse B; Demay MB; Amling M
Bone; 2017 Oct; 103():78-87. PubMed ID: 28666969
[TBL] [Abstract][Full Text] [Related]
13. Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice.
Weinstein RS; O'Brien CA; Almeida M; Zhao H; Roberson PK; Jilka RL; Manolagas SC
Endocrinology; 2011 Sep; 152(9):3323-31. PubMed ID: 21771887
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation.
Qing H; Ardeshirpour L; Pajevic PD; Dusevich V; Jähn K; Kato S; Wysolmerski J; Bonewald LF
J Bone Miner Res; 2012 May; 27(5):1018-29. PubMed ID: 22308018
[TBL] [Abstract][Full Text] [Related]
15. Osteocyte Remodeling of the Lacunar-Canalicular System: What's in a Name?
Heveran CM; Boerckel JD
Curr Osteoporos Rep; 2023 Feb; 21(1):11-20. PubMed ID: 36512204
[TBL] [Abstract][Full Text] [Related]
16. Tunnels in the rock: Dynamics of osteocyte morphogenesis.
Moharrer Y; Boerckel JD
Bone; 2021 Dec; 153():116104. PubMed ID: 34245936
[TBL] [Abstract][Full Text] [Related]
17. [Glucocorticoid and Bone. Osteocytic osteolysis : potential modulation by glucocorticoids].
Matsuo K
Clin Calcium; 2014 Sep; 24(9):1337-42. PubMed ID: 25177006
[TBL] [Abstract][Full Text] [Related]
18. Perilacunar bone tissue exhibits sub-micrometer modulus gradation which depends on the recency of osteocyte bone formation in both young adult and early-old-age female C57Bl/6 mice.
Rux CJ; Vahidi G; Darabi A; Cox LM; Heveran CM
Bone; 2022 Apr; 157():116327. PubMed ID: 35026452
[TBL] [Abstract][Full Text] [Related]
19. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.
Kogawa M; Wijenayaka AR; Ormsby RT; Thomas GP; Anderson PH; Bonewald LF; Findlay DM; Atkins GJ
J Bone Miner Res; 2013 Dec; 28(12):2436-48. PubMed ID: 23737439
[TBL] [Abstract][Full Text] [Related]
20. Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice.
Piemontese M; Xiong J; Fujiwara Y; Thostenson JD; O'Brien CA
Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E587-93. PubMed ID: 27460899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
